Skip to main content

Table 1 Baseline demographics

From: Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study

Number

80

Age*

32 (18–64)

Sex

Males 41 (51), females 39 (49)

Smoking

4 (5), all CD

Disease type

UC 60 (75)

CD 20 (25)

Time since diagnosis (years)*

3 (1–15)

Disease location

 

UC

 

Left-sided

Pancolitis

Ileocolonic

Isolated ileal

Proximal small bowel

31 (52)

29 (48)

14 (70)

5 (25)

1 (5)

Disease Phenotype (CD)

 

Stenosing/penetrating

Inflammatory

12 (60)

8 (40)

Medications

 

Biologics

Immunomodulators

Steroids

Oral Mesalamine

Number of current medications

0

1

2

3

4

40 (50)

57 (71)

15 (19)

51 (64)

3 (4)

16 (20)

38 (47)

20 (25)

3 (4)

Disease activity

 

Partial Mayo score*

HBI*

1 (0–6)

5 (0–15)

  1. Number (percent)
  2. *Median (range)